Clinical Trial Update: A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the exposure, safety, and tolerability of a single dose of FG-4592 (roxadustat) in subjects with moderately diminished liver function c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatic Insufficiency
• Liver Disease

Drugs mentioned

• Roxadustat (roxadustat)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: PK of FG-4592, Hepatic Insufficiency | Phase 1 | Status: COMPLETED